Filed: 8/14/2023ACC: 0001420506-23-001546
📋 What this filing means
IKARIAN CAPITAL, LLC filed this quarterly 13F‑HR report disclosing 94 equity positions with a total reported market value of $627.92M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
94
Positions
$627.92M
Total AUM (reported)
42.08M
Total Shares
Allocation by class
COM$458.40M73.0%
SPONSORED ADR$84.37M13.4%
NAMEN AKT$22.46M3.6%
COM NEW$15.36M2.4%
COM PAR $.01$14.45M2.3%
SPONSORED ADS$12.16M1.9%
CL A$11.77M1.9%
Portfolio Concentration
Top 3$170.42M27.1%
4–10$160.81M25.6%
11–25$169.63M27.0%
Rest$127.07M20.2%
Top 3 weight
27.1%
Top 10 weight
52.7%
Voting Authority Distribution
Total shares with voting rights: 42.08M
Sole
Full voting authority
42.08M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole94
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings94
Rows:
ARGENX SE
SOLEShares170.10K
TypeSH
Market value$66.29M
10.56%
Sole
170.10K
Shared
0.00
None
0.00
ACELYRIN INC
SOLEShares3.02M
TypeSH
Market value$63.09M
10.05%
Sole
3.02M
Shared
0.00
None
0.00
TG THERAPEUTICS INC
SOLEShares1.65M
TypeSH
Market value$41.04M
6.54%
Sole
1.65M
Shared
0.00
None
0.00
BIOMEA FUSION INC
SOLEShares1.50M
TypeSH
Market value$32.91M
5.24%
Sole
1.50M
Shared
0.00
None
0.00
BRIDGEBIO PHARMA INC
SOLEShares1.81M
TypeSH
Market value$31.12M
4.96%
Sole
1.81M
Shared
0.00
None
0.00
APELLIS PHARMACEUTICALS INC
SOLEShares266.80K
TypeSH
Market value$24.31M
3.87%
Sole
266.80K
Shared
0.00
None
0.00
CRISPR THERAPEUTICS AG
SOLEShares400K
TypeSH
Market value$22.46M
3.58%
Sole
400K
Shared
0.00
None
0.00
ASTRAZENECA PLC
SOLEShares250K
TypeSH
Market value$17.89M
2.85%
Sole
250K
Shared
0.00
None
0.00
SAREPTA THERAPEUTICS INC
SOLEShares144.20K
TypeSH
Market value$16.51M
2.63%
Sole
144.20K
Shared
0.00
None
0.00
BIOHAVEN LTD
SOLEShares652.42K
TypeSH
Market value$15.61M
2.49%
Sole
652.42K
Shared
0.00
None
0.00
IMMUNOGEN INC
SOLEShares797.70K
TypeSH
Market value$15.05M
2.40%
Sole
797.70K
Shared
0.00
None
0.00
INSMED INC
SOLEShares685K
TypeSH
Market value$14.45M
2.30%
Sole
685K
Shared
0.00
None
0.00
REPLIMUNE GROUP INC
SOLEShares576.50K
TypeSH
Market value$13.39M
2.13%
Sole
576.50K
Shared
0.00
None
0.00
PROTAGONIST THERAPEUTICS INC
SOLEShares446.40K
TypeSH
Market value$12.33M
1.96%
Sole
446.40K
Shared
0.00
None
0.00
VENTYX BIOSCIENCES INC
SOLEShares374.10K
TypeSH
Market value$12.27M
1.95%
Sole
374.10K
Shared
0.00
None
0.00
REATA PHARMACEUTICALS INC
SOLEShares115.47K
TypeSH
Market value$11.77M
1.87%
Sole
115.47K
Shared
0.00
None
0.00
NUVALENT INC
SOLEShares277.15K
TypeSH
Market value$11.69M
1.86%
Sole
277.15K
Shared
0.00
None
0.00
MERCK & CO INC
SOLEShares100K
TypeSH
Market value$11.54M
1.84%
Sole
100K
Shared
0.00
None
0.00
IDEAYA BIOSCIENCES INC
SOLEShares490.89K
TypeSH
Market value$11.54M
1.84%
Sole
490.89K
Shared
0.00
None
0.00
DISC MEDICINE INC
SOLEShares240.03K
TypeSH
Market value$10.66M
1.70%
Sole
240.03K
Shared
0.00
None
0.00
ACLARIS THERAPEUTICS INC
SOLEShares996.46K
TypeSH
Market value$10.33M
1.65%
Sole
996.46K
Shared
0.00
None
0.00
ARCUS BIOSCIENCES INC
SOLEShares480K
TypeSH
Market value$9.75M
1.55%
Sole
480K
Shared
0.00
None
0.00
BIOMARIN PHARMACEUTICAL INC
SOLEShares100K
TypeSH
Market value$8.67M
1.38%
Sole
100K
Shared
0.00
None
0.00
CRINETICS PHARMACEUTICALS IN
SOLEShares475K
TypeSH
Market value$8.56M
1.36%
Sole
475K
Shared
0.00
None
0.00
IMMUNOVANT INC
SOLEShares402.20K
TypeSH
Market value$7.63M
1.22%
Sole
402.20K
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
ARGENX SESOLE | SPONSORED ADR | 170.10K | SH | $66.29M 10.56% | 170.10K | 0.00 | 0.00 |
ACELYRIN INCSOLE | COM | 3.02M | SH | $63.09M 10.05% | 3.02M | 0.00 | 0.00 |
TG THERAPEUTICS INCSOLE | COM | 1.65M | SH | $41.04M 6.54% | 1.65M | 0.00 | 0.00 |
BIOMEA FUSION INCSOLE | COM | 1.50M | SH | $32.91M 5.24% | 1.50M | 0.00 | 0.00 |
BRIDGEBIO PHARMA INCSOLE | COM | 1.81M | SH | $31.12M 4.96% | 1.81M | 0.00 | 0.00 |
APELLIS PHARMACEUTICALS INCSOLE | COM | 266.80K | SH | $24.31M 3.87% | 266.80K | 0.00 | 0.00 |
CRISPR THERAPEUTICS AGSOLE | NAMEN AKT | 400K | SH | $22.46M 3.58% | 400K | 0.00 | 0.00 |
ASTRAZENECA PLCSOLE | SPONSORED ADR | 250K | SH | $17.89M 2.85% | 250K | 0.00 | 0.00 |
SAREPTA THERAPEUTICS INCSOLE | COM | 144.20K | SH | $16.51M 2.63% | 144.20K | 0.00 | 0.00 |
BIOHAVEN LTDSOLE | COM | 652.42K | SH | $15.61M 2.49% | 652.42K | 0.00 | 0.00 |
IMMUNOGEN INCSOLE | COM | 797.70K | SH | $15.05M 2.40% | 797.70K | 0.00 | 0.00 |
INSMED INCSOLE | COM PAR $.01 | 685K | SH | $14.45M 2.30% | 685K | 0.00 | 0.00 |
REPLIMUNE GROUP INCSOLE | COM | 576.50K | SH | $13.39M 2.13% | 576.50K | 0.00 | 0.00 |
PROTAGONIST THERAPEUTICS INCSOLE | COM | 446.40K | SH | $12.33M 1.96% | 446.40K | 0.00 | 0.00 |
VENTYX BIOSCIENCES INCSOLE | COM | 374.10K | SH | $12.27M 1.95% | 374.10K | 0.00 | 0.00 |
REATA PHARMACEUTICALS INCSOLE | CL A | 115.47K | SH | $11.77M 1.87% | 115.47K | 0.00 | 0.00 |
NUVALENT INCSOLE | COM | 277.15K | SH | $11.69M 1.86% | 277.15K | 0.00 | 0.00 |
MERCK & CO INCSOLE | COM | 100K | SH | $11.54M 1.84% | 100K | 0.00 | 0.00 |
IDEAYA BIOSCIENCES INCSOLE | COM | 490.89K | SH | $11.54M 1.84% | 490.89K | 0.00 | 0.00 |
DISC MEDICINE INCSOLE | COM | 240.03K | SH | $10.66M 1.70% | 240.03K | 0.00 | 0.00 |
ACLARIS THERAPEUTICS INCSOLE | COM | 996.46K | SH | $10.33M 1.65% | 996.46K | 0.00 | 0.00 |
ARCUS BIOSCIENCES INCSOLE | COM | 480K | SH | $9.75M 1.55% | 480K | 0.00 | 0.00 |
BIOMARIN PHARMACEUTICAL INCSOLE | COM | 100K | SH | $8.67M 1.38% | 100K | 0.00 | 0.00 |
CRINETICS PHARMACEUTICALS INSOLE | COM | 475K | SH | $8.56M 1.36% | 475K | 0.00 | 0.00 |
IMMUNOVANT INCSOLE | COM | 402.20K | SH | $7.63M 1.22% | 402.20K | 0.00 | 0.00 |
Page 1 of 4